Becton Dickinson - 39 Year Stock Price History | BDX

Historical daily share price chart and data for Becton Dickinson since 1983 adjusted for splits. The latest closing stock price for Becton Dickinson as of June 24, 2022 is 250.92.
  • The all-time high Becton Dickinson stock closing price was 285.99 on February 05, 2020.
  • The Becton Dickinson 52-week high stock price is 280.62, which is 11.8% above the current share price.
  • The Becton Dickinson 52-week low stock price is 231.46, which is 7.8% below the current share price.
  • The average Becton Dickinson stock price for the last 52 weeks is 253.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Becton Dickinson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 259.2945 253.2100 277.2400 234.7400 250.9200 -0.22%
2021 248.2635 250.7000 263.3000 235.8300 251.4800 0.50%
2020 247.7151 272.5400 285.9900 200.5800 250.2200 -8.00%
2019 247.3476 220.0800 273.4900 211.2000 271.9700 20.70%
2018 235.8119 217.8400 264.3800 209.8500 225.3200 5.26%
2017 194.8812 165.1500 228.2100 164.8000 214.0600 29.30%
2016 163.8729 147.9500 181.5500 132.8800 165.5500 7.44%
2015 143.9445 139.8600 156.5300 130.4000 154.0900 10.73%
2014 119.3090 109.1400 141.2600 105.4000 139.1600 25.95%
2013 98.0282 79.4500 110.6000 79.4500 110.4900 41.31%
2012 76.3648 74.4500 80.5300 72.1800 78.1900 4.64%
2011 80.2148 84.7300 89.7400 70.6500 74.7200 -11.59%
2010 75.1529 78.6000 85.3200 66.8900 84.5200 7.18%
2009 69.1860 69.8600 79.7200 60.4800 78.8600 15.31%
2008 81.2159 86.7800 92.3400 60.2600 68.3900 -18.17%
2007 78.0784 70.4300 85.3000 69.8500 83.5800 19.14%
2006 65.5807 60.4500 73.7900 58.3100 70.1500 16.76%
2005 56.0083 56.0100 60.7200 50.0700 60.0800 5.77%
2004 49.9393 41.0300 57.8300 41.0300 56.8000 38.07%
2003 36.3223 31.5400 41.4500 29.4500 41.1400 34.05%
2002 32.9676 33.2900 38.4700 25.0100 30.6900 -7.42%
2001 34.6496 34.1900 39.0000 30.1400 33.1500 -4.27%
2000 28.5228 26.1900 35.1300 22.3800 34.6300 28.54%
1999 32.0667 43.0000 43.0000 24.2500 26.9400 -36.89%
1998 37.5524 25.0000 46.8800 24.7500 42.6900 70.76%
1997 24.5123 21.6900 27.6250 21.6900 25.0000 15.26%
1996 20.6494 18.9375 22.3125 17.8750 21.6900 15.68%
1995 14.7626 12.0625 18.9375 12.0625 18.7500 56.25%
1994 10.4039 8.9700 12.4075 8.5625 12.0000 34.27%
1993 9.1946 9.7188 10.0625 8.1875 8.9375 -9.06%
1992 9.2063 8.2975 10.4850 8.2188 9.8275 14.77%
1991 8.8377 9.3438 10.0775 7.2975 8.5625 -8.05%
1990 8.2282 7.8275 9.5000 7.0150 9.3125 20.39%
1989 6.9256 6.4063 7.7650 6.0938 7.7350 19.00%
1988 6.7716 6.4375 7.7025 5.8750 6.5000 1.96%
1987 7.2757 6.3275 8.5625 5.5150 6.3750 2.00%
1986 5.9537 3.8988 7.6100 3.8988 6.2500 61.29%
1985 3.2833 2.4844 4.0700 2.4844 3.8750 56.48%
1984 2.2541 2.3594 2.5469 1.9300 2.4763 7.81%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.140B $20.248B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $45.179B 13.28
AmerisourceBergen (ABC) United States $30.289B 13.97
Laboratory Of America Holdings (LH) United States $22.213B 9.28
West Pharmaceutical Services (WST) United States $22.141B 33.74
Cooper (COO) United States $15.181B 23.36
Cardinal Health (CAH) United States $14.444B 11.09
CONMED (CNMD) United States $2.694B 27.82
Invacare (IVC) United States $0.053B 0.00